"","Num","POD","SD","%","Genes","KE"
"GO:0003158","3","4.06599163182682","0.240590726259354","12.5","acvrl1, met, plod3","IMPAIRMENT ENDOTHELIAL NETWORK"
"CYANOSIS","4","4.14959716059275","0.173020775213535","21.05","acvrl1, agrn, psat1, rnaseh2a","N/A CYANOSIS OCCURS"
"GO:0045444","6","4.66166683710557","0.121456457109253","14.63","arntl1a, atf5b, cebpa, cebpb, sirt1, xbp1","INCREASED ADIPOGENESIS"
"G TGF BETA SIGNALING PATHWAY","6","4.75128675454445","0.0788013164633454","8.82","acvrl1, mycb, rps6kb1b, smad1, tfdp1a, tgfb3","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"VASCULAR CALCIFICATION","2","4.75641461607375","0.241420958444422","40","ldlra, rnaseh2a","OSTEOPOROSIS AND VASCULAR CALCIFICATION BONE DETERIORATION"
"GO:0016209","2","5.23993835841606","0.164982855423074","18.18","apoeb, gsr","OXIDATION GLUTATHIONE"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","4","5.29479864434409","0.0362548845522451","15.38","casp9, jun, mapkapk2a, rb1","ACTIVATION FAS; UP REGULATION FAS"
"GO:0006635","5","5.59302252630861","0.063433532036268","25","acaa2, acadm, acat1, cpt2, hadh","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"REGULATION OF SPINDLE CHECKPOINT","3","5.75529053890698","0.0897480168728994","100","ccnb1, mad2l1, tprb","UPREGULATED SPINDLE ASSEMBLY CHECKPOINT PROTEIN MAD2-OOCYTE"
"TRIGLYCERIDE METABOLIC PROCESS","3","5.85133435935995","0.124942352322401","18.75","apoeb, ldlra, sirt1","ACCUMULATION TRIGLYCERIDE"
"ABNORMAL LACTATE DEHYDROGENASE LEVEL","4","5.90343393400449","0.0707661850161931","44.44","acadm, chek2, mycb, rb1","DOWN REGULATION GULCOSE-6-PHOSPHATE DEHYDROGENASE"
"GLUTATHIONE METABOLIC PROCESS","3","5.98722613402405","0.0948520734636942","30","gclm, gsr, nfe2l2a","GLUTATHIONE SYNTHESIS; GLUTATHIONE HOMEOSTASIS"
"BLOOD CLOTTING CASCADE","2","6.10911450211894","0.165147206636652","20","f3a, serpine1","HEMOSTASIS DEPLETION FROM BLOOD OF FULLY FUNCTIONAL CARBOXYLATED CLOTTING FACTORS"
"GO:0010463","2","6.33505485374831","0.18203349535836","16.67","fgfr1b, mycb","INCREASED PROLIFERATION OF MESENCHYMAL CELLS"
"CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP","4","6.35944227911519","0.0874121615020639","33.33","cyp51, fdps, lss, rxraa","UP REGULATION SREBF2"
"ABNORMAL CIRCULATING FATTY ACID CONCENTRATION","4","6.37473204253914","0.0841023331085094","44.44","acad8, acadm, cpt2, hadh","ACCUMULATION FATTY ACID"
"DECREASED PLASMA CARNITINE","4","6.37473204253914","0.0841023331085094","57.14","acad8, acadm, cpt2, hadh","REDUCTION PLASMA VITELLOGENIN CONCENTRATIONS; INCREASE PLASMA VITELLOGENIN CONCENTRATIONS; DECREASED RENAL PLASMA FLOW; INCREASED PLASMA TYROSINE; DECREASED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA"
"GO:0051899","3","6.51063814279667","0.0696769775596893","14.29","gclm, jun, tspo","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT; PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE"
"GO:0004872","22","6.54025357686529","0.0176998089731149","9.21","acvrl1, bdnf, csf1ra, epha2a, f3a, fgfr1b, fzd2, fzd7a, glra4a, igf1ra, igf1rb, insra, met, opn1lw1, opn1mw1, opn1mw2, opn1sw2, rxraa, tgfb3, thraa, thrab, vegfaa","ACTIVATION PXR/SXR"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","3","6.58578889232862","0.143877143152609","27.27","apoeb, ldlra, nup107","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"GO:0007612","3","6.67268466441529","0.164025245808687","12.5","hif1ab, insra, jun","IMPAIRMENT LEARNING AND MEMORY"
"MATING BEHAVIOR","2","6.86510305822134","0.00619501795843867","22.22","hdac1, thraa","REDUCED ABILITY TO ATTRACT SPAWNING MATES"
"REPRODUCTIVE BEHAVIOR","2","6.86510305822134","0.00619501795843867","20","hdac1, thraa","REDUCED SPAWNING BEHAVIOR"
"HEART DEVELOPMENT","12","6.88725436511921","0.0364292805182369","9.52","acvrl1, cad, ccnb1, eif4g2b, fzd2, hif1ab, mapk11, pcna, raf1b, rb1, smad1, vegfaa","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"TUBE FEEDING","3","7.07766405269814","0.144279601037733","17.65","fgfr1b, psat1, puf60a","INHIBITION FEEDING"
"GO:0005515","10","7.08913771165973","0.0592053503920874","21.28","arntl1a, arntl2, bmp1a, e2f7, fgfr1b, hsp90aa1.1, hsp90aa1.2, myb, thraa, vegfaa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"G JAK STAT SIGNALING PATHWAY","4","7.13352791514081","0.0623915382094305","25","jak1, mycb, ptpn6, stat3","ACTIVATION JAK/STAT PATHWAY"
"GO:0006629","38","7.20109360296911","0.0110749281364251","18.45","acaa2, acad8, acadm, acat1, agrn, alas1, aldh1a3, apoeb, atp6v1ba, baxa, cebpa, cpt2, crk, cyp1b1, cyp24a1, cyp51, fdps, fgfr1b, hacd3, hadh, hdac3, hsd11b1la, ldlra, lias, lss, lypla2, naga, opn1lw1, pgp, pigs, ptges, rb1, rxraa, scd, sirt1, thraa, tspo, xbp1","ALTERATION LIPID METABOLISM"
"GO:0042698","3","7.23821955484144","0.0454008664601228","13.64","pcna, sirt1, tgfb3","IRREGULARITIES OVARIAN CYCLE"
"GO:0006636","3","7.25085047494217","0.168883262615171","25","ptges, scd, sirt1","UP REGULATION UNSATURATED FATTY ACID"
"NEURODEGENERATION","5","7.36350418919973","0.0224152163247642","33.33","ccnf, fth1a, hnrnpa1b, pcna, rnaseh2a","N/A NEURODEGENERATION"
"CTOME FOXO MEDIATED TRANSCRIPTION","5","7.4470468484592","0.0463018070571278","17.86","bbc3, hdac1, igfbp1b, sirt1, ywhabb","ACTIVATION FOXO"
"GO:0006412","7","7.45346650052258","0.053872633794827","6.48","eif2b4, eif3d, farsa, gars, iars, rars, yars","ALTERED PROTEIN PRODUCTION"
"GO:0007568","26","7.4896396681056","0.0163188241772538","30.23","apex1, arntl1a, casp9, cdk1, chek1, chek2, ctsc, ctsla, fbxo5, gclm, igfbp1b, igfbp5b, jun, msh2, msh6, nfe2l2a, rad54l, rela, rps6kb1b, serpine1, sirt1, stat3, tgfb3, timp2a, tspo, tyms","ACCELERATED AGING"
"GO:0030331","2","7.49663991398813","0.0857062941726065","22.22","pcna, ppid","INCREASED ER BINDING TO DNA CLASSICAL PATHWAY; INCREASED ER BINDING TO TF TO DNA NON-CLASSICAL PATHWAY"
"GO:0003824","13","7.55938917983897","0.0242850594779059","20","acaa2, acat1, alas1, aldh18a1, cth, got2a, lias, naga, odc1, ppm1ab, psat1, rrm1, uqcrc1","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"NEUROINFLAMMATION","2","7.5813468460426","0.185937885691537","16.67","jun, rela","N/A NEUROINFLAMMATION"
"GO:0030545","3","7.61147231469748","0.0860713145848752","5.08","bdnf, bmp1a, tgfb3","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"GO:0050673","16","7.64275602931739","0.024282998815065","19.51","acvrl1, apoeb, baxa, cebpb, f3a, fgfr1b, hif1ab, igfbp5b, jun, map2k2a, mmp14b, mycb, rb1, sirt1, stat3, xbp1","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"HEPATOCELLULAR CARCINOMA","3","7.72539945207717","0.0567577182583521","23.08","met, msh2, msh6","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"GO:0015631","5","7.73635176039502","0.030477783848328","26.32","atf5b, cenpe, plk1, rae1, tprb","BINDING TUBULIN"
"GO:0044703","25","7.74522086206198","0.0168747539991415","21.55","arntl1a, atrx, aurka, baxa, birc2, cad, ccnb1, cdk1, ctsla, fbxo5, got2a, hsf1, igfbp5b, mmp9, msh2, plk1, ppat, rps6kb1b, rxraa, sirt1, stat3, tgfb3, thraa, ttk, vdac2","N/A REPRODUCTIVE FAILURE"
"GO:0006898","7","7.76041811408657","0.0664247626650079","18.42","apoeb, cd63, hsp90aa1.2, insra, ldlra, serpine1, syk","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"CTOME FATTY ACYL COA BIOSYNTHESIS","2","7.76173949575738","0.420765411829437","40","hacd3, scd","UP REGULATION ACETYL-COA CARBOXYLASE-1 ACC-1"
"GO:0006305","2","7.76440596568727","0.181471728071167","66.67","cebpb, dnmt1","ALKYLATION DNA; FORMATION PRO-MUTAGENIC DNA ADDUCTS"
"GO:0042060","17","7.89624010443617","0.0242293759623827","19.32","acvrl1, apoeb, ccnb1, crk, f3a, gna12a, hdac1, hif1ab, igfbp1b, nfe2l2a, ptpn6, raf1b, serpine1, syk, tgfb3, usf1, xbp1","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"REGULATION OF WNT SIGNALING PATHWAY","8","7.89665577583215","0.0363374376919626","10.13","apoeb, csnk1a1, csnk1db, hdac1, igfbp1b, igfbp6b, psmc2, psmd14","INHIBITION WNT PATHWAY"
"GO:0030154","6","7.95127591363286","0.0509632178976968","9.23","agrn, rb1, rxraa, thraa, thrab, vegfaa","DIFFERENTIATION OF MYOFIBROBLAST"
"ELECTRON TRANSPORT CHAIN","7","8.0120647565583","0.0454516845685731","10.29","ccnb1, cdk1, ciapin1, gsr, ndufs2, phgdh, uqcrc1","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0005102","33","8.05327290353484","0.0121942065200973","15.87","apoeb, arntl1a, atp2a2b, bdnf, bmp1a, ccnb1, cebpb, crk, fgfr1b, gna12a, gnai1, gnat2, hif1ab, igf1ra, igfbp1b, igfbp6b, insra, jak1, mmp14b, pcna, ppid, prpf6, rb1, rxraa, serpine1, sirt1, stat3, syk, taf11, tgfb3, timp2a, ufd1l, yars","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"G VEGF SIGNALING PATHWAY","6","8.16153807507897","0.0306893595268486","28.57","casp9, map2k2a, mapk11, mapkapk2a, raf1b, vegfaa","REDUCED PRODUCTION VEGF"
"GO:0007051","16","8.16308964387266","0.0156889129360916","59.26","atrx, aurka, ccnb1, cdc20, cenpe, chek2, csnk1db, fbxo5, gnai1, hdac3, mybl2b, plk1, rae1, tacc3, tprb, ttk","DISORGANIZATION SPINDLE"
"G OOCYTE MEIOSIS","12","8.17630902496937","0.0211746210889485","30","aurka, ccnb1, cdc20, cdc23, cdk1, cdk2, fbxo5, igf1ra, mad2l1, plk1, ppp1cb, ywhabb","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"GO:0032964","2","8.19725319848057","0.0719066824429888","20","myb, tgfb3","ACCUMULATION COLLAGEN; EXPRESSION OF COLLAGEN"
"GO:0006954","22","8.24157833668382","0.0143277133254655","18.8","abcf1, apoeb, birc2, cebpa, cebpb, ctsc, f3a, hif1ab, jun, kars, ldlra, lias, mapkapk2a, mmp13a, mmp9, nfe2l2a, ptges, rb1, rela, serpine1, stat3, syk","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:1904019","4","8.24986587137126","0.0665997148159461","18.18","nfe2l2a, pak4, rb1, serpine1","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS"
"GO:0043542","8","8.30653194190961","0.0599133948273619","22.86","acvrl1, apoeb, cyp1b1, fgfr1b, hif1ab, met, nfe2l2a, sirt1","INCREASED MIGRATION ENDOTHELIAL CELLS"
"GO:0001935","10","8.32646396617973","0.0453988160769915","27.78","acvrl1, apoeb, f3a, fgfr1b, hif1ab, jun, mmp14b, sirt1, stat3, xbp1","INCREASED PROLIFERATION ENDOTHELIAL CELLS"
"ABNORMALITY OF THE MITOCHONDRION","6","8.35005759771361","0.0529464011780743","4.76","acad8, acadm, cpt2, dnmt1, hadh, ndufs2","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","4","8.3514603274601","0.0993298150434042","8.33","csnk1a1, fzd2, jun, mycb","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"SMOOTH MUSCLE CELL PROLIFERATION","7","8.36293814647646","0.0371492931457292","26.92","dnmt1, igfbp5b, jun, mmp9, myb, rps6kb1b, tgfb3","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"GO:0042116","8","8.39095365233679","0.0516973578284393","53.33","cebpa, ctsc, hspd1, jun, kars, ldlra, mmp13a, syk","INCREASED ACTIVATION AND RECRUITMENT OF HEPATIC MACROPHAGES KUPFFER CELLS"
"GO:0009611","25","8.41333815096077","0.0141416099705406","22.32","acvrl1, apoeb, aurka, baxa, ccnb1, cdk1, crk, dhfr, f3a, gna12a, hdac1, hif1ab, igfbp1b, jun, map2k2a, nfe2l2a, ptpn6, raf1b, rps6kb1b, serpine1, syk, tgfb3, tspo, usf1, xbp1","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0000003","45","8.45006975967316","0.0080143846319293","22.17","arntl1a, atrx, aurka, baxa, birc2, bub3, cad, ccnb1, ccnf, cdc20, cdk1, cdk2, cebpa, cebpb, ctsla, e2f7, e2f8, eif2b4, fbxo5, got2a, hif1ab, hsf1, igfbp5b, insra, mmp14b, mmp9, msh2, msh6, nup107, pcna, plk1, ppat, rad54l, rpa1, rps6kb1b, rrm1, rxraa, sirt1, smc4, stat3, tgfb3, thraa, ttk, vdac2, zw10","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"NEOPLASM OF THE SKIN","7","8.52122642543291","0.0386463694800022","21.21","ctsc, dkc1, fdps, fgfr1b, msh2, msh6, tars","SENSITISATION SKIN"
"REGULATION OF ATPASE ACTIVITY","5","8.54695094335881","0.0266800009106747","31.25","dnajc1, msh2, msh6, pfn2l, sirt1","INHIBITION CA++ ATPASE"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","12","8.54801097611722","0.0216257321173783","11.11","apex1, cdk2, gna12a, gnai1, igf1ra, jak1, jun, mycb, raf1b, rb1, rps6kb1b, stat3","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"UPPER MOTOR NEURON DYSFUNCTION","32","8.57901240765596","0.00954570824332163","6.75","acat1, aldh18a1, atrx, bdnf, cars, ccnf, ctsd, dkc1, dnmt1, eif2b4, fgfr1b, fth1a, got2a, hnrnpa1b, hspd1, iars, lias, msh2, msh6, naga, nars, ndufs2, nup107, nup133, odc1, phgdh, pola1, pqbp1, psat1, rars, rnaseh2a, tars","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"DECREASED BODY WEIGHT","39","8.61673820949345","0.00968308956356339","17.26","acadm, acat1, aldh18a1, atrx, birc2, bmp1a, cars, cdc45, cdc6, cenpe, chek2, cyp24a1, dkc1, farsb, fgfr1b, fip1l1b, got2a, hadh, iars, igf1ra, jak1, map2k2a, mcm5, msh2, msh6, ndufs2, nfe2l2a, orc1, phgdh, pola1, ppp1cb, pqbp1, psat1, puf60a, rb1, srsf2a, stat3, tgfb3, ufd1l","DECREASED BODY WEIGHT"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","45","8.62730326801826","0.00721633005134197","11.14","acad8, acat1, acvrl1, apoeb, atrx, baxa, birc2, bub3, cad, cebpa, chek2, cpt2, dhfr, dkc1, farsa, farsb, fip1l1b, gsr, hadh, hspa9, jak1, map2k2a, mcm4, met, msh2, msh6, mycb, ndufs2, phgdh, plod3, prkcsh, puf60a, raf1b, rb1, rnaseh2a, rras, sec61a1, serpine1, srp72, srsf2a, stat3, tars, tgfb3, thraa, ufd1l","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"G GLUTATHIONE METABOLISM","6","8.64737781362269","0.0489247603070689","75","gclm, gsr, odc1, pgd, rrm1, rrm2","DEPLETION GSH"
"ESTROGEN RECEPTOR PATHWAY","3","8.64942674762513","0.0939585714768352","16.67","cyp1b1, jun, stat3","ACTIVATION ESTROGEN RECEPTOR"
"PARALYSIS","6","8.74915599296572","0.0470128677400885","26.09","aldh18a1, ccnf, fgfr1b, hnrnpa1b, pola1, rars","INDUCTION SOMATIC MUSCLE PARALYSIS; INDUCTION PHARYNGEAL MUSCLE PARALYSIS"
"GO:0009790","35","8.75457008206568","0.00927896004561123","20.71","acvrl1, aldh1a3, atp6v1ba, baxa, ccnb1, cdk1, cebpa, cebpb, cpt2, dnmt1, e2f7, e2f8, fbl, fgfr1b, fzd2, gna12a, hdac1, hif1ab, hsf1, insra, lias, mmp13a, mmp14b, mmp9, msh2, nfe2l2a, nmt1a, nup133, phgdh, plod3, rxraa, smad1, ssr2, tgfb3, xab2","DEFECT OF EMBRYOGENESIS"
"ABNORMALITY OF THE ABDOMINAL ORGANS","37","8.7973661941941","0.00916626097303784","21.89","acadm, acat1, acvrl1, apoeb, atrx, chek2, cpt2, ctsc, dhfr, dkc1, farsa, farsb, hadh, hnrnpa1b, iars, jak1, ldlra, mcm4, met, msh2, msh6, mycb, naga, ndufs2, pigs, pold1, prkcsh, puf60a, raf1b, rela, rnaseh2a, rras, serpine1, srsf2a, stat3, tars, ufd1l","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","34","8.81529414467986","0.0101387714291431","4.53","acadm, acat1, acvrl1, apoeb, atrx, cpt2, ctsc, dhfr, dkc1, farsa, farsb, hadh, hnrnpa1b, iars, jak1, ldlra, mcm4, met, msh2, msh6, mycb, naga, ndufs2, pigs, pold1, prkcsh, raf1b, rela, rnaseh2a, rras, srsf2a, stat3, tars, ufd1l","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"GLOMERULAR SCLEROSIS","4","8.83639392972761","0.0479604690913481","28.57","nup107, nup133, nup93, sec61a1","DECREASED GLOMERULAR FILTRATION"
"GO:0015908","5","8.85058885196616","0.0630065064310631","22.73","apoeb, cpt2, got2a, rps6kb1b, syk","INCREASED FA INFLUX"
"ENDOMETRIAL CANCER","6","8.85856838474544","0.0402426088621804","8.82","baxa, casp9, fgfr1b, map2k2a, mycb, raf1b","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"CARCINOMA","3","8.91281186279844","0.107607909717234","60","dkc1, msh2, pold1","PROMOTION HEPATOCELLUAR CARCINOMA"
"APOPTOSIS","8","8.91303366285412","0.033355585442452","14.29","baxa, bbc3, birc2, casp9, igf1ra, jun, mycb, rela","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL"
"ABNORMALITY OF THE OVARY","9","8.94117776365614","0.0231624650821093","15.79","chek2, eif2b4, fgfr1b, mmp14b, msh2, msh6, mycb, nup107, rela","REDUCED PROSTAGLANDINS OVARY"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","3","8.98095621990285","0.031215899723455","2.94","hdac1, rxraa, sirt1","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"SOMATIC MUTATION","10","9.00098244175585","0.0251150800454484","11.9","aurka, baxa, cebpa, chek2, fgfr1b, met, msh6, mycb, rad54l, rb1","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"GO:0009058","2","9.05005193355265","0.208415324586799","28.57","alas1, got2a","INCREASED TRIGLYCERIDE FORMATION; INCREASED TRIGLYCERIDE FORMATION; DECREASE TETRAHYDROBIOPTERIN; ROS FORMATION"
"GO:0003714","8","9.06560713567256","0.0323865821658887","40","apex1, atf5b, e2f7, e2f8, hdac1, hdac3, sirt1, srsf2a","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"GO:0005488","223","9.07698665177722","0.0014544140054435","20.72","abcf1, acad8, acadm, acat1, acvrl1, adssl, agrn, ahr2, alas1, aldh18a1, alyref, apex1, apoeb, arntl1a, arntl2, atad5a, atf5b, atf6, atp2a2b, atp6v1ba, atrx, aurka, baxa, bcl2a, bdnf, birc2, bmp1a, bub3, cad, cars, cdc20, cdc45, cdc6, cdc7, cdk1, cdk2, cebpa, cebpb, cenpe, chek1, chek2, ciapin1, cnot4b, cops5, cpsf1, creb3l3l, csf1ra, csnk1a1, csnk1db, csnk2a2a, cth, cyp1b1, cyp24a1, cyp2ad2, cyp2ad3, cyp2ad6, cyp2k18, cyp51, dhfr, dhx15, dkc1, dnajc1, dnmt1, e2f3, e2f7, e2f8, eftud2, eif2b4, eif3d, eif4g2b, epha2a, ewsr1b, farsa, farsb, fbl, fbxo5, fgfr1b, fip1l1b, fth1a, fzd2, fzd7a, gars, gclm, glra4a, gna12a, gnai1, gnat2, gnl3, got2a, gsr, hadh, hat1, hdac1, hdac3, hif1aa, hif1ab, hmgcrb, hnrnpa1b, hsf1, hsp70.1, hsp70.1, hsp90aa1.1, hsp90aa1.2, hspa9, hspd1, iars, igf1ra, igf1rb, igfbp1a, igfbp1b, igfbp5b, igfbp6b, insra, jak1, jun, kars, ldlra, lias, lig1, lig3, map2k2a, mapk11, mapkapk2a, mcm4, mcm5, met, mmp13a, mmp14a, mmp14b, mmp17b, mmp9, msh2, msh6, myb, mybl2b, mycb, nars, ndufs2, nfe2l2a, nploc4, orc1, pak4, patl1, pcna, pfn2l, pgd, phgdh, plk1, plod3, pola1, pola2, pold1, pold2, pom121, pop7, ppat, ppid, ppm1ab, ppp1cb, pqbp1, prkcsh, prpf40a, psat1, psmc2, psmd14, ptpn4a, puf60a, rad54l, rae1, raf1a, raf1b, rars, rassf1, rb1, rela, rfc3, rfc5, rnaseh2a, rpa1, rpa2, rps6kb1b, rras, rrm1, rrm2, rxraa, sae1, scd, sec23a, sec61a1, sephs1, sf3b3, sgk1, sirt1, smad1, smarcb1b, smc4, snrpc, srp72, srsf2a, srsf2b, stat3, syk, taf11, tardbp, tars, tfdp1a, tgfb3, thop1, thraa, thrab, timp2a, timp2b, ttk, u2af1, uba2, ubr7, ufd1l, uqcrc1, usf1, vdac2, vegfaa, xbp1, yars","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"ABNORMAL LIVER MORPHOLOGY","29","9.09830984589936","0.0124556666570723","24.37","acadm, acat1, acvrl1, apoeb, atrx, cpt2, ctsc, dhfr, dkc1, farsa, farsb, hadh, hnrnpa1b, iars, jak1, ldlra, mcm4, met, naga, ndufs2, pigs, pold1, prkcsh, raf1b, rnaseh2a, rras, srsf2a, stat3, tars","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"GO:0030163","41","9.10934128611472","0.00906031593101551","26.8","apoeb, arntl1a, aurka, birc2, bub3, ccnb1, ccnf, cdc20, cdc23, cdk1, cdk2, cebpa, chek2, cnot4b, csnk1a1, csnk1db, ctsc, ctsd, ctsla, cyp51, fbxo5, gna12a, hsp90aa1.2, ldlra, lypla2, mad2l1, nfe2l2a, nploc4, odc1, plk1, psmc2, psmd14, rela, sec22bb, sf3b3, sirt1, timp2a, ube4b, ufd1l, usp1, xbp1","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0046983","49","9.11735627773889","0.00718336486249789","24.87","acat1, aldh1a3, apoeb, arntl1a, arntl2, atf6, aurka, baxa, cars, cebpa, cebpb, chek2, e2f3, e2f8, fgfr1b, gars, gclm, got2a, hif1ab, hsf1, hsp90aa1.2, hspb6, jun, kars, mad2l1, msh2, mycb, naga, odc1, pola2, raf1b, rela, rrm2, rxraa, sae1, smc4, snrpc, stat3, taf11, taf5, tars, tfdp1a, tgfb3, tprb, ttk, tyms, uba2, usf1, xbp1","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","15","9.13779794936795","0.0238848080088531","14.56","atrx, eif2b4, fgfr1b, fip1l1b, lss, nup107, phgdh, pola1, pold1, prpf6, psat1, raf1b, rras, serpine1, stat3","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"GO:0007059","17","9.17019612128033","0.0130896565563419","38.64","atrx, bub3, ccnb1, cdc20, cdc23, cdc6, cenpe, fbxo5, mad2l1, nup37, plk1, rb1, smc4, tacc3, tprb, ttk, zw10","INCREASED CHROMOSOME MISSEGGREGATION"
"MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION","3","9.18783074076139","0.13983556898337","30","csnk1db, fbxo5, met","DEPOLYMERIZATION MICROTUBULE"
"SQUAMOUS CELL CARCINOMA","4","9.20725278703082","0.0881452804135227","40","ctsc, dkc1, fdps, tars","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS; INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA; SQUAMOUS METAPLASIA ABERRANT BASAL CELLS"
"NRF2 PATHWAY","7","9.23186526052243","0.0452286637485914","17.5","fth1a, gclm, gsr, hsp90aa1.2, nfe2l2a, pgd, rxraa","ACTIVATION NRF2"
"DNA DAMAGE RESPONSE","11","9.25104610091111","0.0267673841545555","18.97","baxa, bbc3, casp9, ccnb1, cdk1, cdk2, chek1, chek2, mycb, rb1, rpa2","INCREASED DNA DAMAGE-REPAIR"
"GO:0001775","32","9.33899943599317","0.00905023381474645","16.33","apoeb, atad5a, atp6v1d, baxa, cd63, cebpa, cebpb, ctsc, ctsd, fth1a, gclm, gna12a, hsp90aa1.2, hspd1, jun, kars, ldlra, mmp13a, mmp14b, mmp9, msh2, msh6, myb, psmc2, psmd14, ptpn6, raf1b, stat3, syk, thoc1, timp2a, xbp1","ACTIVATION DENDRITIC CELLS"
"GO:0006915","6","9.35007480541699","0.0315818371779322","19.35","bcl2a, casp3a, casp9, ciapin1, rb1, sgk1","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS; DECREASED APOPTOSIS EPITHELIAL CELLS; INCREASED APOPTOSIS DECREASED LEYDIG CELLS"
"LIPID ACCUMULATION IN HEPATOCYTES","11","9.35356859133935","0.034968009919277","34.38","acadm, apoeb, cpt2, farsa, farsb, hadh, hnrnpa1b, iars, ldlra, pold1, tars","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"ABNORMALITY OF THE ENDOMETRIUM","3","9.38970712535949","0.103164150682551","27.27","msh2, msh6, pold1","INCREASED HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASE HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASED ADENOSQUAMOUS CARCINOMAS OF ENDOMETRIUM"
"INCREASED SUSCEPTIBILITY TO FRACTURES","9","9.50252423382337","0.0122602597718256","25.71","chek2, dkc1, fgfr1b, hnrnpa1b, mmp14b, plod3, rb1, srsf2a, stat3","INCREASED DISEASE SUSCEPTIBILITY"
"REGULATION OF PROTEOLYSIS","32","9.50821620897847","0.00758895054358299","28.57","apoeb, aurka, baxa, bbc3, birc2, casp9, cdc20, cebpa, csnk1a1, csnk1db, ctsc, ctsd, dnajc1, f3a, gna12a, hdac1, hsf1, hspd1, mmp14b, mmp9, mycb, nfe2l2a, plk1, psmc2, psmd14, raf1b, serpine1, sirt1, stat3, syk, timp2a, vegfaa","IMPAIRED PROTEOSTASIS"
"GO:0048856","4","9.50890890624691","0.0885776905350099","33.33","igf1ra, igf1rb, insra, rxraa","ALTERED NEUROANATOMY"
"GO:0040011","43","9.56224146118687","0.00762336082834665","18.94","acvrl1, agrn, apex1, apoeb, baxa, bdnf, cd63, cdk1, creb3l3l, crk, cyp1b1, epha2a, f3a, fbxo5, fgfr1b, gna12a, hif1ab, igf1ra, igfbp5b, insra, jun, kars, lypla2, map2k2a, met, mmp14b, mmp9, nfe2l2a, pak4, pfn2l, ppid, prpf40a, ptpn6, raf1b, rps6kb1b, rras, serpine1, sgk1, sirt1, stat3, syk, tspo, xbp1","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048870","39","9.5626732520519","0.00861877478020575","19.5","acvrl1, apex1, apoeb, baxa, cd63, cdk1, creb3l3l, crk, cyp1b1, epha2a, f3a, fbxo5, fgfr1b, gna12a, hif1ab, igf1ra, igfbp5b, insra, jun, kars, map2k2a, met, mmp14b, mmp9, nfe2l2a, pak4, pfn2l, prpf40a, ptpn6, raf1b, rps6kb1b, rras, serpine1, sgk1, sirt1, stat3, syk, tspo, xbp1","INCREASED MOTILITY"
"MORTALITY AGING","6","9.56733736446302","0.0313655340705666","23.08","atrx, msh2, msh6, phgdh, pqbp1, rnaseh2a","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"BLADDER CANCER","7","9.57277817924311","0.0326824288958505","16.67","map2k2a, mmp9, mycb, raf1b, rassf1, rb1, vegfaa","INCREASE CANCER"
"GO:0004882","7","9.60180227512971","0.0301671296833805","20","cdk1, hdac1, jun, raf1a, rb1, rela, stat3","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"GO:0008152","2","9.72001851850088","0.128282792622345","66.67","naga, rrm1","PRODUCTION CRITICAL METABOLITES CGA 330050 AND CGA 265307; METABOLISM OF AFB1 PRODUCTION OF REACTIVE ELECTROPHILES"
"ARYL HYDROCARBON RECEPTOR PATHWAY","6","9.75177505725028","0.0633456548365162","12.5","baxa, cyp1b1, hsp90aa1.2, igfbp1b, jun, nfe2l2a","UP REGULATION CYP1A1; ACTIVATION AHR"
"GO:0016310","32","9.75794738768621","0.010688679404322","25.6","acvrl1, aldh18a1, aurka, cdc7, cdk1, cdk2, chek1, chek2, csf1ra, csnk1a1, csnk1db, csnk2a2a, epha2a, fgfr1b, igf1ra, igf1rb, insra, jak1, map2k2a, mapk11, mapkapk2a, met, pak4, plk1, prkcsh, raf1a, raf1b, rps6kb1b, sephs1, sgk1, syk, ttk","ACTIVATION SP1"
"CELL MIGRATION AND INVASION THROUGH P75NTR","5","9.75981648980409","0.064513416676393","27.78","bdnf, jun, mmp13a, mmp9, stat3","INCREASED INVASION"
"LUNG FIBROSIS","3","9.835118414477","0.11091058420476","8.33","cebpb, mmp9, nfe2l2a","LUNG FIBROSIS"
"GO:0046903","37","9.84131357420818","0.0104299318378451","16.02","apoeb, arntl1a, atp2a2b, atp6v1d, cad, cd63, cops5, ctsc, ctsd, cyp51, dnajc1, fgfr1b, fth1a, got2a, hadh, hif1ab, hsp90aa1.2, kars, mapk11, mmp13a, mmp9, myb, pfn2l, ppat, ppid, psmc2, psmd14, ptpn6, raf1b, serpine1, sgk1, slc29a1a, syk, tardbp, tgfb3, timp2a, xbp1","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0006633","6","9.95928200522889","0.0762439604906909","20.69","hacd3, lias, ptges, scd, sirt1, xbp1","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","36","10.0057444773698","0.00915326014717314","24.49","acvrl1, agrn, aldh18a1, apoeb, atrx, birc2, bub3, ccnf, cdc45, chek2, ctsc, dkc1, farsa, farsb, fgfr1b, fip1l1b, hnrnpa1b, mcm4, msh2, msh6, nfe2l2a, nup107, phgdh, pola1, ppp1cb, psat1, puf60a, raf1b, rb1, rela, rras, srsf2a, stat3, tars, tgfb3, ufd1l","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0042701","16","10.01839633435","0.0162613304363892","47.06","aurka, ccna2, ccnb1, cdc23, cdk1, cdk2, gnai1, hsp90aa1.1, hsp90aa1.2, igf1ra, igf1rb, mad2l1, mapk11, plk1, raf1a, raf1b","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"GO:0045333","5","10.0360788264214","0.0688532718622984","6.94","ccnb1, cdk1, hif1ab, ndufs2, uqcrc1","INCREASE OXIDATIVE METABOLISM"
"ABNORMAL RENAL TUBULE MORPHOLOGY","4","10.0599418018112","0.0554672847290266","44.44","cpt2, ndufs2, nup107, nup133","OCCURRENCE CYSTIC DILATATION RENAL TUBULE; OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE"
"GO:0072358","26","10.0695126572586","0.01376320836158","23.42","acvrl1, apoeb, baxa, cth, cyp1b1, dnmt1, e2f7, e2f8, epha2a, f3a, fgfr1b, hif1ab, hspb6, jak1, jun, ldlra, mmp14b, nfe2l2a, pak4, rras, serpine1, sirt1, smad1, stat3, syk, xbp1","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"ABNORMAL NASAL MORPHOLOGY","27","10.0699546275407","0.00963802303381476","17.42","atrx, bub3, cars, cenpe, cpt2, ctsd, eftud2, fgfr1b, fzd2, hspa9, igf1ra, lss, map2k2a, naga, odc1, pigs, plod3, ppp1cb, pqbp1, prpf6, psat1, puf60a, raf1b, rb1, sec23a, stat3, ufd1l","INCREASE SITE OF CONTACT NASAL TUMORS"
"VENTRICULAR ARRHYTHMIA","3","10.1060751112453","0.059631320485948","42.86","ndufs2, raf1b, tgfb3","OCCURRENCE CARDIAC ARRHYTHMIA"
"GO:0008213","2","10.1297768978394","0.0998068021631594","28.57","dnmt1, fbl","ALKYLATION PROTEIN"
"GO:0035357","2","10.169036335858","0.00422769678542501","66.67","rxraa, sirt1","ACTIVATION LXR ALPHA; DECREASED PPAR-ALPHA ACTIVATION; DECREASED PPAR-BETA ACTIVATION; DECREASED PPAR-GAMMA ACTIVATION; INHIBITION PPAR ALPHA; ACTIVATION OF SPECIFIC NUCLEAR RECEPTORS PPAR-GAMMA ACTIVATION; INCREASED PPAR-ALPHA ACTIVATION"
"REGULATION OF CELL DEATH","62","10.1706939924958","0.00405185216908915","23.13","acaa2, aldh1a3, apex1, apoeb, atf5b, atf6, aurka, baxa, bbc3, bdnf, birc2, casp9, cdk1, cebpb, chek2, ciapin1, cops5, creb3l3l, cth, ctsc, ctsd, cyp1b1, dnmt1, e2f3, fgfr1b, gclm, hdac1, hdac3, hif1ab, hsf1, hsp90aa1.2, hspa9, hspb6, hspd1, igf1ra, jun, mad2l1, met, mmp9, msh2, myb, mybl2b, mycb, nfe2l2a, pak4, plk1, ppid, ptpn6, raf1b, rb1, rela, rps6kb1b, serpine1, sgk1, sirt1, syk, tgfb3, thraa, tspo, vdac2, vegfaa, xbp1","N/A CELL INJURY/DEATH"
"GO:0099536","10","10.2245327919245","0.0260084664326584","9.01","agrn, apoeb, atp2a2b, bdnf, cdc20, gnai1, pfn2l, rela, slc29a1a, stat3","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"PEPTIDYL LYSINE MODIFICATION","23","10.2338767419643","0.00839766888954046","32.39","atrx, chek1, cth, dnmt1, gnl3, hat1, hdac1, lias, myb, nup107, nup133, nup37, nup50, nup93, plod3, pom121, rae1, rela, sae1, sirt1, taf5, tprb, uba2","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"PYRUVATE METABOLIC PROCESS","9","10.2416897754382","0.0233744998498075","16.07","hif1ab, nup107, nup133, nup37, nup50, nup93, pom121, rae1, tprb","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GO:0016055","6","10.271645065607","0.0492276069309837","26.09","csnk1a1, csnk1db, fzd2, fzd7a, hdac1, met","ALTERATION WNT PATHWAY"
"RENAL TUBULAR DYSFUNCTION","4","10.320748662219","0.102424424336744","15.38","atp6v1ba, cad, ndufs2, stat3","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0001816","25","10.3718691675861","0.0102308621910813","20.83","birc2, cebpa, cebpb, cyp1b1, fgfr1b, hif1ab, hsf1, hspd1, kars, mapk11, mapkapk2a, mmp13a, myb, nploc4, pqbp1, ptpn6, rela, serpine1, sirt1, stat3, syk, tgfb3, tspo, ufd1l, xbp1","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0006839","10","10.4199376675795","0.0300954238577591","21.74","acaa2, baxa, cpt2, hsp90aa1.2, hspd1, nmt1a, sae1, stat3, tfdp1a, tspo","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"BREAST CANCER PATHWAY","12","10.4387018613394","0.019758560157289","10.53","baxa, csnk1a1, e2f3, fgfr1b, fzd2, igf1ra, jun, map2k2a, mycb, raf1b, rb1, rps6kb1b","N/A BREAST CANCER"
"ABNORMAL NEURON MORPHOLOGY","3","10.4403399754967","0.0875845623570492","18.75","aldh18a1, ccnf, hnrnpa1b","HYPERPOLARISATION NEURON"
"NEGATIVE REGULATION OF FAT CELL PROLIFERATION","2","10.4737982604211","0.062790320702209","50","e2f3, tfdp1a","INDUCTION SUSTAINED CELL PROLIFERATION"
"SANDAL GAP","2","10.4889117643348","0.133680363318881","40","cenpe, igf1ra","N/A GAP"
"GO:0048469","10","10.501825331058","0.032268447359204","41.67","agrn, aurka, ccnb1, cebpa, fbxo5, fgfr1b, hif1ab, rb1, tyms, xbp1","INCREASED OOCYTE MATURATION"
"GO:0019904","28","10.5447776828564","0.00893025731096312","22.76","atrx, baxa, casp9, ccna2, cdk2, chek1, crk, fgfr1b, fzd2, hdac1, hif1ab, hnrnpa1b, hsp90aa1.2, insra, jun, map2k2a, nfe2l2a, ptpn6, rb1, rela, rps6kb1b, rrm1, rxraa, sirt1, srp72, syk, tfdp1a, thraa","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"ABNORMAL LUNG MORPHOLOGY","31","10.5614786338486","0.0112408009360162","24.22","acvrl1, agrn, aldh18a1, apoeb, birc2, bub3, cdc45, chek2, ctsc, dkc1, farsa, farsb, fgfr1b, fip1l1b, mcm4, nfe2l2a, nup107, phgdh, pola1, ppp1cb, psat1, puf60a, raf1b, rb1, rela, rras, srsf2a, stat3, tars, tgfb3, ufd1l","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"RESPONSE TO ESTRADIOL","4","10.5834747614987","0.0509721816396744","13.33","ccna2, hsf1, pcna, stat3","REDUCTION PLASMA 17BETA-ESTRADIOL CONCENTRATIONS"
"GO:0022414","9","10.5881827430412","0.030755229536177","25","ahr2, aurka, ccnb1, fbxo5, igf1rb, msh6, rad54l, rpa1, ttk","INCREASED REPRODUCTIVE SUCCESS"
"CHOLESTASIS","4","10.636487010562","0.0828684223769954","11.43","dhfr, farsb, iars, rnaseh2a","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"RESPONSE TO REACTIVE OXYGEN SPECIES","18","10.6432180216672","0.0132587190965657","32.14","apex1, apoeb, ccna2, cdk2, crk, cyp1b1, dhfr, hdac1, hif1ab, hsf1, jun, met, mmp9, myb, nfe2l2a, pcna, rela, sirt1","INCREASED REACTIVE OXYGEN SPECIES"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","6","10.683411330047","0.037146640126272","17.65","crk, jun, map2k2a, met, raf1b, stat3","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"GLUCOCORTICOID RECEPTOR PATHWAY","4","10.7328510468863","0.0909935260377875","16.67","birc2, hsp90aa1.2, jun, rxraa","ACTIVATION GLUCOCORTICOID RECEPTOR"
"ABNORMALITY OF THE PITUITARY GLAND","7","10.8436500264132","0.025256220358403","14.58","farsa, fgfr1b, msh2, msh6, nup107, pola1, puf60a","INCREASED ADENOMAS PITUITARY"
"GO:0001909","3","10.9872660357796","0.0779471365891564","50","crk, ctsc, ptpn6","INCREASE CYTOTOXICITY"
"IMMUNOLOGIC HYPERSENSITIVITY","6","11.0092148819308","0.0183162743159597","26.09","fgfr1b, jak1, odc1, srsf2a, stat3, ufd1l","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE"
"HYPERACTIVITY","9","11.0490134065632","0.0212211700537666","18","atrx, cars, fgfr1b, msh2, msh6, odc1, pola1, puf60a, ufd1l","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"POSITIVE REGULATION OF GENE EXPRESSION","29","11.0499452038573","0.00908708663053208","16.02","cebpb, chek1, cyp1b1, dnmt1, eif3d, eif4g2b, f3a, hdac1, hif1ab, hsp90aa1.2, hspd1, map2k2a, mapk11, mapkapk2a, mmp13a, mmp14b, msh2, myb, mycb, nfe2l2a, pqbp1, rela, rps6kb1b, serpine1, smad1, stat3, syk, vegfaa, xbp1","ALTERED GENE EXPRESSION"
"ABNORMAL OVARIAN MORPHOLOGY","3","11.2500334458265","0.0401266660268287","8.11","fgfr1b, mmp14b, nup107","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"ABNORMAL SOCIAL BEHAVIOR","5","11.2879019112886","0.0697728027377049","19.23","ndufs2, pola1, puf60a, rars, tars","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR"
"GO:0006281","33","11.3760298959307","0.00665935127043357","38.82","apex1, atrx, cdc45, cdc7, cdk1, cdk2, chek1, chek2, cops5, hsf1, lig1, lig3, mcm4, mcm5, msh2, msh6, nploc4, pcna, pola1, pold1, pold2, pold3, psmd14, rad54l, rfc3, rfc5, rnaseh2a, rpa1, rpa2, sirt1, ufd1l, usp1, xab2","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"GO:0042446","4","11.6830559499693","0.054668968493362","14.29","dio1, hif1ab, hsd11b1la, tspo","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"GO:1903409","6","11.7890347940918","0.0568326120004223","24","cyp1b1, hsp90aa1.2, insra, mmp13a, stat3, tspo","INCREASE ROS PRODUCTION; PRODUCTION REACTIVE OXYGEN SPECIES"
"GO:0008283","2","11.8710361805531","0.0517515158654886","22.22","stat3, tacc3","PROLIFERATION CELL PROLIFERATION IN THE ABSENCE OF CYTOTOXICITY; ACTIVATION/PROLIFERATION T-CELLS; ALTERATIONS CELLULAR PROLIFERATION / HYPERPLASIA; INCREASE PROLIFERATION LEYDIG CELL; INCREASE MITOGENIC CELL PROLIFERATION HEPATOCYTES; INCREASE HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; INCREASE REGENERATIVE CELL PROLIFERATION CORNEAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION FORESTOMACH EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION HEPATOCYTES; INCREASE REGENERATIVE CELL PROLIFERATION UROTHELIAL CELLS; INCREASE CELL PROLIFERATION; INCREASE PROLIFERATION OF GOBLET CELLS; INCREASED HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; PROLIFERATION/CLONAL EXPANSION SMOOTH MUSCLE; INCREASED CELLULAR PROLIFERATION / HYPERPLASIA OF ACINAR CELLS; PROLIFERATION/CLONAL EXPANSION ABERRANT BASAL CELLS; INCREASED CELL PROLIFERATION MESOTHELIUM; INCREASE CELL PROLIFERATION EPITHELIAL CELLS"
"GO:0070265","3","12.2139705429301","0.0408517089842715","27.27","baxa, birc2, tspo","INCREASE TISSUE DEGENERATION NECROSIS & ATROPHY; INCREASED ONCOTIC NECROSIS"
"DECREASED FERTILITY","3","12.2342447792739","0.0233347732782422","3.95","fgfr1b, nup107, raf1b","IMPAIRED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; REDUCTION CUMULATIVE FECUNDITY AND SPAWNING; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED TESTOSTERONE"
"GO:0006936","3","12.6626321429039","0.0780877758728345","5.45","atp2a2b, hspb6, rps6kb1b","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","10","12.7816328290062","0.013546220449997","30.3","atrx, bmp1a, fgfr1b, fzd2, hspa9, mmp14b, orc1, plod3, puf60a, sec23a","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"GO:0007249","6","12.9675423043625","0.0364752169805121","13.95","birc2, cth, hacd3, hdac1, rela, sirt1","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R","2","13.6296221517693","0.0532445739540338","15.38","fgfr1b, igf1ra","INCREASED IGF-1 MOUSE"
"CTOME CELLULAR RESPONSE TO HYPOXIA","4","13.8030396118347","0.0442680684909169","9.3","hif1ab, psmc2, psmd14, vegfaa","N/A HYPOXIA"
"GO:1903008","3","13.949587459698","0.0698064889343837","23.08","cdk1, hif1ab, tspo","DISRUPTION LYSOSOME"
"GO:0050663","5","14.1250234755537","0.05655049014407","16.67","kars, mapk11, mmp13a, syk, xbp1","RELEASE CYTOKINE"
"GO:0019882","7","14.2266861623493","0.0299185726534488","11.86","cenpe, ctsd, ctsla, psmc2, psmd14, sec22bb, sec23a","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"RESPONSE TO NITRIC OXIDE","3","14.5944236225828","0.0521146799411181","42.86","ccna2, cdk2, crk","DECREASED NITRIC OXIDE"
"ABNORMALITY OF THE BLADDER","9","15.3631201018825","0.0210312837693104","17.31","aldh18a1, atrx, cdc45, dnmt1, hnrnpa1b, hspa9, hspd1, puf60a, ufd1l","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0019932","4","16.2779334174905","0.0593743450898066","6.56","apoeb, atp2a2b, gnai1, syk","INCREASED SECOND MESSENGER PRODUCTION"
"REGULATION OF PH","2","16.91975768148","0.0718516387014874","14.29","atp6v1ba, atp6v1d","DECREASE INTRACELLULAR PH"
"GO:0044414","5","17.3673453883128","0.0409058000292563","12.5","atp6v1ba, atp6v1d, ctsla, sec22bb, sec61a1","SUPPRESSION IMMUNE SYSTEM"
"CTOME REGULATED NECROSIS","3","17.5372445178182","0.0841241545682275","14.29","baxa, birc2, hsp90aa1.2","INCREASE NECROSIS TERMINAL BRONCHIOLAR CELLS"
"REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY","4","17.6064628291014","0.0618736541537488","50","apoeb, dhfr, hif1ab, hsp90aa1.2","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307"
"CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY","3","17.8790140207383","0.0838394437781826","10","alas1, hsp90aa1.2, rxraa","SUPPRESSION CONSTITUTIVE ANDROSTANE RECEPTOR NR1L3; ACTIVATION CONSTITUTIVE ANDROSTANE RECEPTOR"
"JNK CASCADE","6","18.5587348937888","0.0344482196542243","27.27","cops5, hacd3, hdac3, igf1ra, mmp13a, syk","ACTIVATION JNK"
"LYMPHOCYTE APOPTOTIC PROCESS","2","20.259494070682","0.0562245443590714","25","baxa, hif1ab","DECREASED LYMPHOCYTES"
"HEMOGLOBIN METABOLIC PROCESS","2","20.8337994614521","0.0476403502539616","33.33","alas1, hif1ab","ALTERED REGULATION ALPHA HEMOGLOBIN"
